Literature DB >> 21788945

Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling.

G Epron1, P Ame-Thomas, J Le Priol, C Pangault, J Dulong, T Lamy, T Fest, K Tarte.   

Abstract

Interleukin-15 (IL-15) has been extensively studied for its role in the survival and proliferation of NK and T cells through a unique mechanism of trans-presentation by producer cells. Conversely, whereas activated B cells have been described as IL-15-responding cells, the cellular and molecular context sustaining this effect remains unexplored. In this study, we found that, whereas human B cells could not respond to soluble IL-15, monocytes and lymphoid tissue-derived macrophages but not stromal cells efficiently trans-present IL-15 to normal B cells and cooperate with T-cell-derived CD40L to promote IL-15-dependent B-cell proliferation. Furthermore, CD40L signaling triggers a Src-independent upregulation of STAT5 expression and favors a Src-dependent phosphorylation of STAT5 in response to IL-15. In follicular lymphoma (FL), immunohistochemical studies reported a strong relationship between malignant B cells, infiltrating macrophages and T cells. We show here an overexpression of IL-15 in purified tumor-associated macrophages, and STAT5A in purified tumor B cells. Moreover, FL B cells respond to IL-15 trans-presented by monocytes/macrophages, in particular, in the presence of CD40L-mediated signaling. This cooperation between IL-15 and CD40L reinforces the importance of tumor microenvironment and unravels a mechanism of FL growth that should be considered if using IL-15 as a drug in this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788945     DOI: 10.1038/leu.2011.179

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  26 in total

1.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

2.  A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma.

Authors:  Robert Chen; Paul Frankel; Leslie Popplewell; Tanya Siddiqi; Nora Ruel; Arnold Rotter; Sandra H Thomas; Michelle Mott; Nitya Nathwani; Myo Htut; Auayporn Nademanee; Stephen J Forman; Mark Kirschbaum
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

3.  Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.

Authors:  Rashmi Gupta; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

Review 4.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Authors:  Patricia Amé-Thomas; Sylvia Hoeller; Catherine Artchounin; Jan Misiak; Mounia Sabrina Braza; Rachel Jean; Jérôme Le Priol; Céline Monvoisin; Nadine Martin; Philippe Gaulard; Karin Tarte
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

6.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

Review 7.  B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.

Authors:  G Galletti; F Caligaris-Cappio; M T S Bertilaccio
Journal:  Leukemia       Date:  2016-09-28       Impact factor: 11.528

8.  The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Birgitta Sander; Daphne de Jong; Andreas Rosenwald; Wanling Xie; Olga Balagué; Maria Calaminici; Joaquim Carreras; Philippe Gaulard; John Gribben; Anton Hagenbeek; Marie José Kersten; Thierry Jo Molina; Abigail Lee; Santiago Montes-Moreno; German Ott; John Raemaekers; Gilles Salles; Laurie Sehn; Christoph Thorns; Björn E Wahlin; Randy D Gascoyne; Edie Weller
Journal:  Haematologica       Date:  2014-02-07       Impact factor: 9.941

Review 9.  The tumour microenvironment in B cell lymphomas.

Authors:  David W Scott; Randy D Gascoyne
Journal:  Nat Rev Cancer       Date:  2014-07-10       Impact factor: 60.716

10.  Stromal cell contribution to human follicular lymphoma pathogenesis.

Authors:  Frédéric Mourcin; Céline Pangault; Rada Amin-Ali; Patricia Amé-Thomas; Karin Tarte
Journal:  Front Immunol       Date:  2012-09-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.